Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
US10632119B2 · kind B2 · utility
0Cited by
10References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2018 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Oct 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I) or a salt form thereof. The compound of formula (I) has ALK and FAK inhibitory activity, and may be used to treat proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.